Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients-Reference-Cited by-同舟云学术

Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients

Published:2012-08-06 Issue:3 Volume:48 Page:403-407
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Kröger N,Zabelina T,Klyuchnikov E,Kropff M,Pflüger K-H,Burchert A,Stübig T,Wolschke C,Ayuk F,Hildebrandt Y,Bacher U,Badbaran A,Schilling G,Hansen T,Atanackovic D,Zander A R

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2012142.pdf

Reference27 articles.

1. Badros A, Barlogie B, Siegel E, Cottler-Fox M, Zangari M, Fassas A et al. Improved outcome of allogeneic transplantation in high-risk multiple myeloma patients after nonmyeloablative conditioning. J Clin Oncol 2002; 20: 1295–1303.

2. Giralt S, Aleman A, Anagnostopoulos A, Weber D, Khouri I, Anderlini P et al. Fludarabine/melphalan conditioning for allogeneic transplantation in patients with multiple myeloma. Bone Marrow Transplant 2002; 30: 367–373.

3. Einsele H, Schäfer HJ, Hebart H, Liebisch P, Bamberg M, Faul C et al. Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning. Br J Haematol 2003; 121: 411–418.

4. Lee CK, Badros A, Barlogie B, Morris C, Zangari M, Fassas A et al. Prognostic factors in allogemeic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning. Exp Hematol 2003; 31: 73–80.

5. Shaw BE, Peggs K, Bird JM, Cavenagh J, Hunter A, Madrigal A . for the Clinical Trials Committee of the British Society of Blood and Marrow Transplantation The outcome of unrelated donor stem cell transplantation for patients with multiple myeloma. Br J Haematol 2003; 123: 886–895.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic stem cell transplantation in multiple myeloma: is there still a place?;Frontiers in Oncology;2024-06-04

2. Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review;International Journal of Molecular Sciences;2024-02-12

3. Maintenance therapy after allogeneic hematopoietic stem cell transplantation for patients with multiple myeloma;International Journal of Hematology;2023-04-15

4. Mogamulizumab for post-transplant relapse of adult T-cell leukemia/lymphoma: a case study;International Journal of Hematology;2022-09-09

5. Case 20-2022: A 25-Year-Old Man with Vision Changes;New England Journal of Medicine;2022-06-30